TOIIW | The Oncology Institute, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0122 - 0.0144
52 Week Range	0.0122 - 0.0144
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	976
Average Volume	N/A
Shares Outstanding	814,289,834
Market Cap	13,713,036
Sector	Healthcare
Industry	Medical - Care Facilities
IPO Date	N/A

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	-602.09
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	800
Country	USA

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients. The company was founded in 2007 and is based in Cerritos, California.

TOIIW's peers: PIIIW, TOI, TALKW, SRZNW, ROIVW

*Chart delayed

Analyzing fundamentals for TOIIW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is very weak. For more detailed analysis please see TOIIW Fundamentals page.

Watching at TOIIW technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on TOIIW Technicals page.